DIVIS LABORATORIES
|
|
| BOM : 532488 NSE : DIVISLAB | |
| LT :
Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
| ST :
Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward Pledged Shares : None or < 25% |
Jul 11,2025 |
|
Price(EOD): ₹ 6,833.10
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
| MCap: ₹ 181,418.81 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| DIVIS LABORATORIES | -0.7% | 1.6% | 50.2% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.4% | -0.9% | 4.8% |
| CIPLA | -1.7% | -1.1% | -2.3% |
| TORRENT PHARMACEUTICALS | -1.1% | 1.6% | 13.7% |
| DR REDDYS LABORATORIES | -4.3% | -8% | -4.4% |
| MANKIND PHARMA | 6.8% | 8% | 20.9% |
| ZYDUS LIFESCIENCES | -1.9% | 0.1% | -16.5% |
| LUPIN | -4.3% | -6.4% | 4.6% |
| AUROBINDO PHARMA | -5.1% | -2.7% | -15.3% |
FUNDAMENTAL ANALYSIS OF DIVIS LABORATORIES
[ Q(TTM): Mar2025, Y: Mar2024
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF DIVIS LABORATORIES
[As on : Jul 11,2025
]
| Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
82.79
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 2,191.00 Cr
[Latest Qtr - Mar2025 - Consolidated Results ] 12.12
P/B Calculated based on Book Value of Rs 14,969.00 Cr
[Latest Year - Mar2025 - Consolidated Results ] 19.38
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 9,360.00 Cr
[Latest Qtr - Mar2025 - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
186% 76% 83% |
SHARE PRICE MOMENTUM OF DIVIS LABORATORIES
DIVIS LABORATORIES vs SENSEX
DEBT OF DIVIS LABORATORIES
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2024 2023 2022 Avg_3yrs |
0 0 0 - |
0 0 0 - |
|
[Last Annual Data : Mar2024]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF DIVIS LABORATORIES
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Mar2025 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF DIVIS LABORATORIES
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
11.47% 19.25% 19.01% 12.39% |
12.24% 21.2% 21.18% 23.05% |
| QtrlyTrend |
8 | |
| Latest Qtr: Mar2025 | ||
| Quarterly Result Analysis → | ||
DIVIS LABORATORIES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE LARGEMIDCAP | 4.5% | 7.2% | 8.3% |
| BSE 500 SHARIAH | 4.3% | 4.3% | 1.1% |
| BSE DIVIDEND STABILITY INDEX | -0.9% | -0.7% | -7% |
| BSE 500 | -1.1% | -0.2% | 0.7% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY 500 EQUAL WEIGHT | -0.7% | -0.3% | -0.3% |
| NIFTY PHARMA | -0.7% | 0.8% | 9.4% |
| NIFTY GROWTH SECTORS 15 | -0.8% | 0.6% | 1.3% |
| NIFTY ALPHA QUALITY LOW-VOLATILITY 30 | -0.9% | -0.5% | -6.7% |
| NIFTY NEXT 50 | -0.9% | -1.2% | -7.5% |
You may also like the below Video Courses
FAQ about DIVIS LABORATORIES
Is DIVIS LABORATORIES good for long term investment?
As on Jul 11,2025, the Fundamentals of DIVIS LABORATORIES look Strong and hence it may be good for long term investment! See Financial Performance of DIVIS LABORATORIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is DIVIS LABORATORIES UnderValued or OverValued?
As on Jul 11,2025, DIVIS LABORATORIES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of DIVIS LABORATORIES ?
As on Jul 11,2025, the Intrinsic Value of DIVIS LABORATORIES is Rs. 3,728.67 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 2,387.89
Fair Value [Median EV / Sales Model] : Rs. 3,891.22
Fair Value [Median Price / Sales Model] : Rs. 3,728.67
Estimated Median Fair Value of DIVIS LABORATORIES : Rs. 3,728.67
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
